Rubeosis Anti-VEGF (RAVE)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rubeosis Anti-VEGF (RAVE), covering 2013-03-14 to 2013-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion [Phase 1]